Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Synaptogenix Has Been Granted U.S. Patent Number 12,016,837 Titled "Halogenated Esters Of Cyclopropanated Unsaturated Fatty Acids For Use In The Treatment Of Neurodegenerative Diseases (Including Alzheimer's Disease)"

Author: Benzinga Newsdesk | June 25, 2024 11:46am

https://ppubs.uspto.gov/pubwebapp/external.html?q=(12016837).pn

Posted In: SNPX